References
- Zangari, M., Anaissie, E., Barlogie, B., et al, (2001) “Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy”, Blood 98, 1614–1615.
- Baron, J.A., Gridley, G., Weiderpass, E., Nyren, O. and Linet, M. (1998) “Venous thromboembolism and cancer”, Lancet 351, 1077–1080.
- Osman, K. and Comenzo, R. (2001) “Deep venous thrombosis and thalidomide therapy for myeloma”, N. Engl]. Med. 344, 1951–1952.
- Barlogie, B., Desikan, R., Eddlemon, P., el al, (2001) “Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide; identification of prognostic factors in a phase 2 study of 169 patients”, Blood 98, 492–494.
- Flageul, B., Wallach, D., Cavelier-Balloy, B., Bachelez, H., Carsuzaa, F. and Dubertret, L. (2000) “Thalidomide et thromboses”, Ann. Dermatol. Venereol. 127(2), 171–174.